Basic Information
RNALocate ID: | RLID:11002398 |
RNA Symbol: | hsa-miR-30e-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-30e-5p |
RNA ID: | miRBase:MIMAT0000692 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002004 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002005 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002006 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11002395 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002396 | Exosome | Breast milk | 22211110 |
RLID:11002397 | Exosome | Brain tissue | 23382797 |
RLID:11002399 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002400 | Exosome | Serum | 25349172 |
RLID:11002401 | Extracellular Vesicle | Plasma | 28588009 |
RLID:11002402 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11002403 | Microvesicle | Plasma | 23077538 |
RLID:11002404 | Microvesicle | Seminal plasma | 23539611 |
RLID:11002405 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000115 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000404 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-30e-5p | Diffuse large b cell lymphoma | MNDR-E-MI-37716 |
MNDR | hsa-miR-30e-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-37717 |
MNDR | hsa-miR-30e-5p | Oral squamous cell carcinoma | MNDR-E-MI-37718 |
MNDR | hsa-miR-30e-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-37719 |
MNDR | hsa-miR-30e-5p | Lymphoma | MNDR-E-MI-37720 |
MNDR | hsa-miR-30e-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-37721 |
MNDR | hsa-miR-30e-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-37722 |
MNDR | hsa-miR-30e-5p | Dermatomyositis | MNDR-E-MI-37723 |
MNDR | hsa-miR-30e-5p | Prostate cancer | MNDR-E-MI-37724 |
MNDR | hsa-miR-30e-5p | Gastric cancer | MNDR-E-MI-37725 |
MNDR | hsa-miR-30e-5p | Alzheimer disease | MNDR-E-MI-37726 |
MNDR | hsa-miR-30e-5p | Intracranial aneurysm | MNDR-E-MI-37727 |
MNDR | hsa-miR-30e-5p | Bladder cancer | MNDR-E-MI-37728 |
MNDR | hsa-miR-30e-5p | Esophageal carcinoma | MNDR-E-MI-37729 |
MNDR | hsa-miR-30e-5p | Duchenne muscular dystrophy | MNDR-E-MI-37730 |
MNDR | hsa-miR-30e-5p | Head and neck cancer | MNDR-E-MI-37731 |
MNDR | hsa-miR-30e-5p | Leukemia | MNDR-E-MI-37732 |
MNDR | hsa-miR-30e-5p | Huntington disease | MNDR-E-MI-37733 |
MNDR | hsa-miR-30e-5p | Chorea | MNDR-E-MI-37734 |
MNDR | hsa-miR-30e-5p | Cardiovascular disease | MNDR-E-MI-37735 |
MNDR | hsa-miR-30e-5p | Moyamoya disease | MNDR-E-MI-37736 |
MNDR | hsa-miR-30e-5p | Lung cancer | MNDR-E-MI-37737 |
MNDR | hsa-miR-30e-5p | Down syndrome | MNDR-E-MI-37738 |
MNDR | hsa-miR-30e-5p | Parkinson disease | MNDR-E-MI-37739 |
MNDR | hsa-miR-30e-5p | Thyroid cancer | MNDR-E-MI-37740 |
MNDR | hsa-miR-30e-5p | Pancreatic cancer | MNDR-E-MI-37741 |
MNDR | hsa-miR-30e-5p | Melanoma | MNDR-E-MI-37742 |
MNDR | hsa-miR-30e-5p | Rectum adenocarcinoma | MNDR-E-MI-37743 |
MNDR | hsa-miR-30e-5p | Nephroblastoma | MNDR-E-MI-37744 |
MNDR | hsa-miR-30e-5p | Colon cancer | MNDR-E-MI-37745 |
MNDR | hsa-miR-30e-5p | Colon adenocarcinoma | MNDR-E-MI-37746 |
MNDR | hsa-miR-30e-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-37747 |
MNDR | hsa-miR-30e-5p | Familial ovarian cancer | MNDR-E-MI-37748 |
MNDR | hsa-miR-30e-5p | Prostate adenocarcinoma | MNDR-E-MI-37749 |
MNDR | hsa-miR-30e-5p | Carcinoma ductal breast | MNDR-E-MI-37750 |
MNDR | hsa-miR-30e-5p | Glioblastoma | MNDR-E-MI-37751 |
MNDR | hsa-miR-30e-5p | Glioma | MNDR-E-MI-37752 |
MNDR | hsa-miR-30e-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-37753 |
MNDR | hsa-miR-30e-5p | Osteosarcoma | MNDR-E-MI-37754 |
MNDR | hsa-miR-30e-5p | Liposarcoma | MNDR-E-MI-37755 |
MNDR | hsa-miR-30e-5p | Inclusion body myositis | MNDR-E-MI-37756 |
MNDR | hsa-miR-30e-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-37757 |
MNDR | hsa-miR-30e-5p | Meningioma | MNDR-E-MI-37758 |
MNDR | hsa-miR-30e-5p | Gastric adenocarcinoma | MNDR-E-MI-37759 |
MNDR | hsa-miR-30e-5p | Lung squamous cell carcinoma | MNDR-E-MI-37760 |
MNDR | hsa-miR-30e-5p | Carcinoma lung non-small-cell | MNDR-E-MI-37761 |
MNDR | hsa-miR-30e-5p | Lung adenocarcinoma | MNDR-E-MI-37762 |
MNDR | hsa-miR-30e-5p | Adrenocortical cancer | MNDR-E-MI-37763 |
MNDR | hsa-miR-30e-5p | Thyroid carcinoma | MNDR-E-MI-37764 |
MNDR | hsa-miR-30e-5p | Bladder urothelial carcinoma | MNDR-E-MI-37765 |
MNDR | hsa-miR-30e-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-37766 |
MNDR | hsa-miR-30e-5p | Carcinoma renal cell | MNDR-E-MI-37767 |
MNDR | hsa-miR-30e-5p | Clear cell renal cell carcinoma | MNDR-E-MI-37768 |
MNDR | hsa-miR-30e-5p | Large cell carcinoma | MNDR-E-MI-37769 |
MNDR | hsa-miR-30e-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-37770 |
MNDR | hsa-miR-30e-5p | Cholangiocarcinoma | MNDR-E-MI-37771 |
MNDR | hsa-miR-30e-5p | Esophageal cancer | MNDR-E-MI-37772 |
MNDR | hsa-miR-30e-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-37773 |
MNDR | hsa-miR-30e-5p | Testicular germ cell cancer | MNDR-E-MI-37774 |
MNDR | hsa-miR-30e-5p | T acute lymphoblastic leukemia | MNDR-E-MI-37775 |
MNDR | hsa-miR-30e-5p | Acute t cell leukemia | MNDR-E-MI-37776 |
MNDR | hsa-miR-30e-5p | Acute heart failure | MNDR-E-MI-37777 |
MNDR | hsa-miR-30e-5p | Breast invasive carcinoma | MNDR-E-MI-37778 |
MNDR | hsa-miR-30e-5p | Hepatocellular carcinoma | MNDR-E-MI-37779 |
MNDR | hsa-miR-30e-5p | Familiar ovarian carcinoma | MNDR-E-MI-37780 |
MNDR | hsa-miR-30e-5p | B-cell lymphoma | MNDR-E-MI-37781 |
MNDR | hsa-miR-30e-5p | Rheumatoid arthritis | MNDR-E-MI-37782 |
MNDR | hsa-miR-30e-5p | Retinoblastoma | MNDR-E-MI-37783 |
MNDR | hsa-miR-30e-5p | Hodgkin lymphoma | MNDR-E-MI-37784 |
MNDR | hsa-miR-30e-5p | Burkitt lymphoma | MNDR-E-MI-37785 |
MNDR | hsa-miR-30e-5p | Tonsil cancer | MNDR-E-MI-37786 |
MNDR | hsa-miR-30e-5p | Psoriasis | MNDR-E-MI-37787 |
MNDR | hsa-miR-30e-5p | Skin cutaneous melanoma | MNDR-E-MI-37788 |
MNDR | hsa-miR-30e-5p | Skin melanoma | MNDR-E-MI-37789 |
MNDR | hsa-miR-30e-5p | Acute myelocytic leukemia | MNDR-E-MI-37790 |
MNDR | hsa-miR-30e-5p | Colorectal cancer | MNDR-E-MI-37791 |
MNDR | hsa-miR-30e-5p | Nasopharynx carcinoma | MNDR-E-MI-37792 |
MNDR | hsa-miR-30e-5p | Acute lymphocytic leukemia | MNDR-E-MI-37793 |
MNDR | hsa-miR-30e-5p | Cardiomegaly | MNDR-E-MI-37794 |
MNDR | hsa-miR-30e-5p | Nasopharyngeal cancer | MNDR-E-MI-37795 |
MNDR | hsa-miR-30e-5p | Sleep deprivation | MNDR-E-MI-37796 |
MNDR | hsa-miR-30e-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-37797 |
MNDR | hsa-miR-30e-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-37798 |
MNDR | hsa-miR-30e-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37799 |
MNDR | hsa-miR-30e-5p | Stroke lacunar | MNDR-E-MI-37800 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AC254633.1 | Homo sapiens | RR00032114 |
TOP